CXCR2 and ovarian carcinoma: This was especially evident in genes such as Il1b [shown to be increased in malignant ascites in ovarian cancer patients (56)], Ym1 (a marker for immunosuppressing M2 macrophages), and Cxcr2 (expressed in inflammatory monocytes).